Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 90 | 7,617 | 216 | -3,122 | 0 |
| Gross Profit | 90 | 7,617 | 216 | -3,122 | N/A |
| Operating Expenses | 3,382 | 4,395 | 2,810 | 3,921 | 3,956 |
| Operating Income | -3,293 | 3,223 | -2,593 | -7,043 | -3,956 |
| Other Income | 224 | 291 | 312 | 392 | 407 |
| Pre-tax Income | -3,068 | 3,514 | -2,282 | -6,651 | -3,549 |
| Income Tax | -1 | 0 | 1 | N/A | N/A |
| Net Income Continuous | -3,068 | 3,514 | -2,282 | -6,651 | -3,549 |
| Net Income | $-3,069 | $3,514 | $-2,282 | $-6,651 | $-3,549 |
| EPS Basic Total Ops | -0.57 | 0.66 | -0.42 | -1.26 | -0.68 |
| EPS Basic Continuous Ops | -0.57 | 0.66 | -0.43 | -1.26 | -0.68 |
| EPS Diluted Total Ops | -0.57 | 0.66 | -0.43 | -1.27 | -0.68 |
| EPS Diluted Continuous Ops | -0.57 | 0.66 | -0.43 | -1.26 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.56 | 0.66 | -0.42 | N/A | N/A |
| EBITDA(a) | $-3,480 | $3,016 | $-2,788 | $-7,277 | $-4,202 |